secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001477932-23-006179
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health H1 2023 adjusted net income jumps 3550% to $3.01M, revenue down 6%
--------------------------------------------------------------------------------

- Q2 2023 revenue $12.36M (-6.4% YoY); H1 revenue $24.71M (-6.0% YoY) on currency headwinds.
- H1 adjusted net income $3.01M vs loss of $0.09M in H1 2022; adjusted EBITDA $3.01M (+182% YoY).
- Book value per share exceeds $4.04; stockholders' equity up 12.9% to $44.35M.
- Acquired Cana Laboratories (GMP certified) and Bikas distribution network (50 pharmacies, >$10M annual revenue expected).
- Property & equipment up 488% to $10.7M; goodwill & intangibles up 435% to $3.78M from Q4 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/0001477932-23-006179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223006179/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-006179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer